Ferring Pharmaceuticals today announced it has advanced three studies in the ADSTILADRIN® (nadofaragene firadenovec-vncg) clinical trial program ? two studies in patients with non-muscle invasive ...
Hansa Biopharma, "Hansa" and Genethon, a pioneer and a leader in gene therapy research and development for rare genetic diseases, today announced initiation of GNT-018-IDES, a Phase 2 trial in ...
A new program at the University of South Carolina is helping fill openings for counselors and therapists in schools that most need them. South Carolina public schools reported 30 unfilled counselor ...